[The role of tumor necrosis factor in inflammation].
The paper presents up-to-date information about the action of the tumor necrosis factor in inflammatory pathology. It underlines the fact that a new category of medicines appeared: anti-TNF monoclonal antibodies which can offer new therapeutic perspective in the treatment of intraocular inflammation.